| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 10/08/2009 | CA2720168A1 Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same |
| 10/07/2009 | EP2106440A2 Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus |
| 10/07/2009 | CN101553567A Method for inhibiting or treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 10/07/2009 | CN101548932A Disposable photophobic photosencitizer storage and release member and production method thereof |
| 10/07/2009 | CN100547070C Attenuated circovirus |
| 10/07/2009 | CN100547069C Production of viruses, viral isolates and vaccines |
| 10/07/2009 | CN100547001C HBV precore protein capable of forming particles |
| 10/06/2009 | USRE40930 Porcine adenovirus type 3 genome |
| 10/06/2009 | US7598362 Hepatitis C virus vaccine |
| 10/06/2009 | US7598072 cell-free method for release of viral cores of enveloped viruses from endosomes |
| 10/06/2009 | US7598071 Infectious clone of human parvovirus B19 and methods |
| 10/06/2009 | US7598070 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 10/06/2009 | CA2284689C Animal model for evaluation of vaccines |
| 10/01/2009 | WO2009120895A2 Recombinant bacteriophages useful for tissue engineering |
| 10/01/2009 | WO2009120883A2 Virus-like particle mediated cellular delivery |
| 10/01/2009 | WO2009099716A9 Novel vaccines against multiple subtypes of dengue virus |
| 10/01/2009 | WO2002074916A9 Reg-like protein immunoglobulin derived proteins, compositions, methods and uses |
| 10/01/2009 | US20090247639 Sulfonic acid and aldehyde condensation polymers for the treatment and prevention of hpv |
| 10/01/2009 | US20090247612 Prevention of viral infectivity |
| 10/01/2009 | US20090247473 Acythiols and component thiol compositions as anti-hiv and anti-retroviral agents |
| 10/01/2009 | US20090246855 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 10/01/2009 | US20090246854 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 10/01/2009 | US20090246830 Recombinant influenza viruses for vaccines and gene therapy |
| 10/01/2009 | US20090246829 Sequence analysis of the tetravalent rotavirus vaccine |
| 10/01/2009 | US20090246750 Devices and Methods for Collection, Storage and Transportation of Biological Specimens |
| 10/01/2009 | US20090246226 Avian vaccines possessing a positive marker gene |
| 10/01/2009 | US20090246216 Novel attenuated poliovirus |
| 10/01/2009 | US20090246193 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 10/01/2009 | CA2719938A1 Lentivirus-based immunogenic vectors |
| 09/30/2009 | EP1407007B1 Attenuated circovirus |
| 09/30/2009 | CN101548009A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 09/29/2009 | US7595042 Treating cancer in humans; obtain human, administer antitumor agent, evaluate tumor response to antitumor agents |
| 09/29/2009 | CA2425852C Cytomegalovirus intron a fragments |
| 09/29/2009 | CA2184297C Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 09/24/2009 | WO2009117307A2 Viruses lacking epithelial cell receptor entry |
| 09/24/2009 | WO2009115917A2 Improvements in preparation of influenza virus vaccine antigens |
| 09/24/2009 | WO2009114942A1 Thymidylate kinase fusions and uses thereof |
| 09/24/2009 | WO2009114895A1 Diagnostic, therapeutic and prophylactic method and screening method |
| 09/24/2009 | US20090239816 Multitargeting Interfering RNAs And Methods Of Their Use And Design |
| 09/24/2009 | US20090239287 immortalized human embryonic retinoblast cell; can be cultured under defined serum free conditions, and the cells show improved capability for propagating virus; eliminates the necessity to use whole chicken embryos for the production of influenza vaccines |
| 09/24/2009 | US20090239286 avian cell line infected with orthomyxovirus, paramyxovirus or orthopoxvirus; smallpox, influenza, measles; useful for the mass production of vaccines |
| 09/24/2009 | US20090239285 Tandem reapeat dna constructs producing proteins that attack plant pathogenic viruses, fungi, and bacteria by disrupting transcription factors essential for replication thereof in plants |
| 09/24/2009 | US20090239281 Moving A Small Object in A Direction |
| 09/24/2009 | US20090239265 Virus like particles |
| 09/24/2009 | US20090239261 ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs) |
| 09/24/2009 | US20090238844 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 09/24/2009 | US20090238843 Recombinant mva capable of expressing structural hcv antigens |
| 09/24/2009 | US20090238794 Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
| 09/24/2009 | CA2718430A1 Improvements in preparation of influenza virus vaccine antigens |
| 09/24/2009 | CA2709981A1 Pre- or post-exposure treatment for filovirus or arenavirus infection |
| 09/23/2009 | EP2102332A2 Method for amplifying hcv in aedes mosquitoes |
| 09/23/2009 | EP1097213B1 Vaccine against staphylococcus intoxication |
| 09/23/2009 | CN101538558A ABeta1-40 recombinant adenovirus and method for preparing Alzheimer disease model thereby |
| 09/23/2009 | CN101538557A Recombinant human divalent metal ion transporter adenovirusm and preparation method and application thereof |
| 09/23/2009 | CN101538556A Method for replicating adenovirus by way of selection and mutual compensation |
| 09/23/2009 | CN100543132C A novel human virus causing severe acute respiratory syndrome (SARS) and uses thereof |
| 09/23/2009 | CN100542614C Virus envelope vector for gene transfer |
| 09/22/2009 | US7592171 Vibrio cholerae with improved biological safety features in freeze dried form |
| 09/22/2009 | US7592170 Selective precipitation of viruses using polyectrolytes |
| 09/22/2009 | US7592169 Methods and compositions for treatment and prevention of HSV-2 infections and conditions |
| 09/22/2009 | US7592014 Stabilized viral envelope proteins and uses thereof |
| 09/22/2009 | CA2508139C Escape mutants of newcastle disease virus as marker vaccines |
| 09/22/2009 | CA2295957C Canine interleukin 18, canine interleukin 1.beta. converting enzyme, dna sequences encoding these, interleukin 18 production method and canine immune disease remedy |
| 09/22/2009 | CA2223703C Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| 09/17/2009 | WO2009114504A2 Reducing conjugative plasmids in bacteria |
| 09/17/2009 | WO2009112448A1 Novel tool for the analysis of neural circuits |
| 09/17/2009 | WO2009111892A1 Microrna mediated oncolytic targeting |
| 09/17/2009 | WO2009082664A8 Genetically modified attenuated vesicular stomatitis virus, compositions and methods of use thereof |
| 09/17/2009 | WO2005072129A9 Production of host cells containing mutiple integrating vectors by serial transduction |
| 09/17/2009 | US20090234101 Directed evolution of novel binding proteins |
| 09/17/2009 | US20090233988 Therapeutic Agents for Diseases Associated With Apoptotic Degeneration in Ocular Tissue Cells That Use SIV-PEDF Vectors |
| 09/17/2009 | US20090233972 Substituted heterocycles as anti-infectives |
| 09/17/2009 | US20090233334 Cell cultivation and production of recombinant proteins by means of an orbital shake bioreactor system with disposable bags at the 1,500 liter scale |
| 09/17/2009 | US20090232846 Pestivirus mutant for use in a vaccine |
| 09/17/2009 | US20090232842 HPV Vaccine Comprising Peptides From Host Cell Proteins |
| 09/17/2009 | US20090232841 Optimzed vaccines to provide protection against ebola and other viruses |
| 09/17/2009 | US20090232822 Lung disease targets and uses thereof |
| 09/17/2009 | US20090232800 E1-minus adenoviruses and use thereof |
| 09/17/2009 | US20090232770 Process of production of bacteriophage compositions and methods in phage therapy field |
| 09/17/2009 | CA2718052A1 Reducing conjugative plasmids in bacteria |
| 09/16/2009 | EP2100955A2 Attenuated mutants of human parainfluenza virus type 1 (HPIV1) |
| 09/16/2009 | EP2099903A2 Modified polymerases and attenuated viruses and methods of use thereof |
| 09/16/2009 | CN100540662C Method for purifying viral vaccine by mixed bed gel filtration chromatography |
| 09/16/2009 | CN100540051C Modified vaccinia virus ankara for the vaccination of neonates |
| 09/15/2009 | US7589069 Replication-competent anti-cancer vectors |
| 09/15/2009 | US7588929 Improved bacteriophage compositions comprising specific sugars that reduce or abolish the bacterial phage-neutralizing activity; used to treat infectious diseases |
| 09/15/2009 | US7588888 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 09/15/2009 | US7588771 anticancer treatment by administering a recombinant vaccina virus of a modified TK thymidine kinase and HA hemagglutinin gene; virus does not accumulate to toxic levels in non-targeted organs |
| 09/15/2009 | US7588770 Recombinant viruses of the paramyxoviridae family with heterologous envelope glycoproteins |
| 09/15/2009 | US7588769 Recombinant influenza virus comprising a mutant membrane protein gene, e.g., a mutant integral membrane protein gene such as a mutant type III integral membrane protein gene, which does not encode a functional membrane protein or a functional portion thereof; use in gene therapy |
| 09/15/2009 | US7588768 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/15/2009 | US7588767 Recombinant vaccina virus of a modified TK and HA gene and optionally a modified F3 gene or locus; virus does not accumulate to toxic levels in non-targeted organs |
| 09/15/2009 | CA2421683C Microparticles for delivery of the heterologous nucleic acids |
| 09/15/2009 | CA2032158C Multivalent repressor of gene function |
| 09/14/2009 | CA2625811A1 Microrna mediated oncolytic targeting |
| 09/11/2009 | WO2009110644A1 Recombinant vaccinia virus having hepatitis c virus gene |
| 09/11/2009 | WO2009109086A1 Method for extracting rabies viruses |
| 09/11/2009 | CA2717626A1 Recombinant vaccinia virus having hepatitis c virus gene |
| 09/10/2009 | US20090227664 Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same |
| 09/10/2009 | US20090227030 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |